| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A review of lifestyle and environment risk factors for pancreatic cancer
|
Zanini, Sara
|
|
|
145 |
C |
p. 53-70
|
article
|
| 2 |
Association between different scale bars in dermoscopic images and diagnostic performance of a market-approved deep learning convolutional neural network for melanoma recognition
|
Winkler, Julia K.
|
|
|
145 |
C |
p. 146-154
|
article
|
| 3 |
Association between pelvic inflammatory disease and subsequent salpingectomy on the risk for ovarian cancer
|
Falconer, Henrik
|
|
|
145 |
C |
p. 38-43
|
article
|
| 4 |
Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study
|
Tosoni, Alicia
|
|
|
145 |
C |
p. 171-178
|
article
|
| 5 |
Avapritinib in unresectable or metastatic PDGFRA D842V-mutant gastrointestinal stromal tumours: Long-term efficacy and safety data from the NAVIGATOR phase I trial
|
Jones, Robin L.
|
|
|
145 |
C |
p. 132-142
|
article
|
| 6 |
Axitinib plus pembrolizumab in patients with advanced renal-cell carcinoma: Long-term efficacy and safety from a phase Ib trial
|
Atkins, Michael B.
|
|
|
145 |
C |
p. 1-10
|
article
|
| 7 |
Body mass index, adiposity and tumour infiltrating lymphocytes as prognostic biomarkers in patients treated with immunotherapy: A multi-parametric analysis
|
Esposito, Angela
|
|
|
145 |
C |
p. 197-209
|
article
|
| 8 |
Cancer predisposition syndromes as a risk factor for early second primary neoplasms after childhood cancer – A national cohort study
|
Waespe, Nicolas
|
|
|
145 |
C |
p. 71-80
|
article
|
| 9 |
CDK12 inhibition enhances sensitivity of HER2+ breast cancers to HER2-tyrosine kinase inhibitor via suppressing PI3K/AKT
|
Li, Hui
|
|
|
145 |
C |
p. 92-108
|
article
|
| 10 |
Complete response upon salvage chemotherapy after anti-PD1 failure: Watch and wait
|
Saleh, Khalil
|
|
|
145 |
C |
p. 155-157
|
article
|
| 11 |
Comprehensive molecular and clinicopathological profiling of desmoid tumours
|
Kohsaka, Shinji
|
|
|
145 |
C |
p. 109-120
|
article
|
| 12 |
Differences in cutaneous melanoma survival between the 7th and 8th edition of the American Joint Committee on Cancer (AJCC). A multicentric population-based study
|
Barreiro-Capurro, Alicia
|
|
|
145 |
C |
p. 29-37
|
article
|
| 13 |
Effect of corticosteroids on the outcome of patients with advanced non–small cell lung cancer treated with immune-checkpoint inhibitors
|
Skribek, Marcus
|
|
|
145 |
C |
p. 245-254
|
article
|
| 14 |
Exceptional response to anti-PD-1 treatment in a patient with metastatic cutaneous hidradenocarcinoma
|
Obermann, H.
|
|
|
145 |
C |
p. 143-145
|
article
|
| 15 |
Germline BRCA1/2 mutations and severe haematological toxicities in patients with breast cancer treated with neoadjuvant chemotherapy
|
Furlanetto, Jenny
|
|
|
145 |
C |
p. 44-52
|
article
|
| 16 |
Immune checkpoint blockade for patients with lung cancer and idiopathic pulmonary fibrosis
|
Duchemann, Boris
|
|
|
145 |
C |
p. 179-182
|
article
|
| 17 |
Immune checkpoint inhibitor–related epidermal necrolysis: A rare condition with poor prognosis
|
He, Chunxia
|
|
|
145 |
C |
p. 194-196
|
article
|
| 18 |
Late onset of subacute cutaneous lupus erythematosus following pembrolizumab therapy
|
Andersson, Niklas W.
|
|
|
145 |
C |
p. 168-170
|
article
|
| 19 |
Meta-analyses of phase 3 randomised controlled trials of third generation aromatase inhibitors versus tamoxifen as first-line endocrine therapy in postmenopausal women with hormone receptor-positive advanced breast cancer
|
Robertson, John. F.R.
|
|
|
145 |
C |
p. 19-28
|
article
|
| 20 |
Outcome of combination therapy using BRAF and MEK inhibitors among Asian patients with advanced melanoma: An analysis of 112 cases
|
Fujisawa, Yasuhiro
|
|
|
145 |
C |
p. 210-220
|
article
|
| 21 |
Perioperative trastuzumab, capecitabine and oxaliplatin in patients with HER2-positive resectable gastric or gastro-oesophageal junction adenocarcinoma: NEOHX phase II trial
|
Rivera, Fernando
|
|
|
145 |
C |
p. 158-167
|
article
|
| 22 |
Radical radiotherapy for paediatric solid tumour metastases: An overview of current European protocols and outcomes of a SIOPE multicenter survey
|
Huijskens, Sophie C.
|
|
|
145 |
C |
p. 121-131
|
article
|
| 23 |
Robustness of convolutional neural networks in recognition of pigmented skin lesions
|
Maron, Roman C.
|
|
|
145 |
C |
p. 81-91
|
article
|
| 24 |
Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study
|
Ito, Kentaro
|
|
|
145 |
C |
p. 183-193
|
article
|
| 25 |
Severe anti-PD1-related meningoencephalomyelitis successfully treated with anti-integrin alpha4 therapy
|
Basin, Sarah
|
|
|
145 |
C |
p. 230-233
|
article
|
| 26 |
Shall we use steroids when treating patients with lung cancer with checkpoint inhibitors?
|
Reinmuth, Niels
|
|
|
145 |
C |
p. 255-257
|
article
|
| 27 |
Survival outcomes associated with corticosteroid use before chemoimmunotherapy in patients with advanced lung cancer
|
Sorial, Mark N.
|
|
|
145 |
C |
p. 234-244
|
article
|
| 28 |
The use of ‘added benefit’ to determine the price of new anti-cancer drugs in France, 2004–2017
|
Rodwin, Marc A.
|
|
|
145 |
C |
p. 11-18
|
article
|
| 29 |
Tumour-infiltrating lymphocyte density is associated with favourable outcome in patients with advanced non–small cell lung cancer treated with immunotherapy
|
Gataa, Ithar
|
|
|
145 |
C |
p. 221-229
|
article
|
Journal description